| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/22/2001 | CA2408719A1 Antiproliferative drug and delivery device |
| 11/22/2001 | CA2408701A1 Compositions and methods for tissue dedifferentiation and regeneration |
| 11/22/2001 | CA2408691A1 Compositions and methods for achieving immune suppression |
| 11/22/2001 | CA2408617A1 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 11/22/2001 | CA2408608A1 Antiinflammatory drug and delivery device |
| 11/22/2001 | CA2408530A1 Novel deoxynucleoside kinase enzyme variants |
| 11/22/2001 | CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides |
| 11/22/2001 | CA2408403A1 Vaccines, immunotherapeutics and methods for using the same |
| 11/22/2001 | CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy |
| 11/22/2001 | CA2408373A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors |
| 11/22/2001 | CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 11/22/2001 | CA2408134A1 G-protein coupled receptors |
| 11/22/2001 | CA2407254A1 Insulin formulation for inhalation |
| 11/22/2001 | CA2404822A1 Fertilization of aged oocytes |
| 11/22/2001 | CA2398979A1 Novel bee venom polypeptides and methods of use thereof |
| 11/22/2001 | CA2380423A1 Peptide pharmaceutical formulations |
| 11/21/2001 | EP1156334A2 Method for screening a substance having promoting activity on hair growth |
| 11/21/2001 | EP1156119A2 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 11/21/2001 | EP1156118A1 Virus vector |
| 11/21/2001 | EP1156110A2 G-protein coupled receptor (HFGAN72Y) |
| 11/21/2001 | EP1156063A1 Antibodies to the granulocyte colony stimulating factor receptor |
| 11/21/2001 | EP1156059A1 Selectively cleavable linkers based on a methionine group and an ester group |
| 11/21/2001 | EP1155701A1 Enteral sorbefacients |
| 11/21/2001 | EP1155700A2 Lymphocyte chemoattractant factor and uses thereof |
| 11/21/2001 | EP1155691A2 Anti-angiogenic compositions and methods of use |
| 11/21/2001 | EP1155690A2 Anti-angiogenic compositions and method of use |
| 11/21/2001 | EP1155689A2 Anti-angiogenic compositions and methods of use |
| 11/21/2001 | EP1155322A1 COMPOUNDS AND METHODS FOR THE DETECTION AND PREVENTION OF $i(T. CRUZI) INFECTION |
| 11/21/2001 | EP1155126A2 Genes associated with diseases of the colon |
| 11/21/2001 | EP1155121A1 Compositions and methods for modulating serum cholesterol |
| 11/21/2001 | EP1155037A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists therof, and their therapeutic uses |
| 11/21/2001 | EP1155036A1 Mite protein |
| 11/21/2001 | EP1155035A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 11/21/2001 | EP1155034A1 Formation and anion-exchange of crystalline echinocandin ammonium salts |
| 11/21/2001 | EP1155030A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase |
| 11/21/2001 | EP1155011A1 Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s |
| 11/21/2001 | EP1154796A1 Novel albumin-free factor viii formulations |
| 11/21/2001 | EP1154788A1 Inhibitors of separin, method for identifying them and uses |
| 11/21/2001 | EP1154787A2 Synergistic combination for treatment of viral-mediated diseases |
| 11/21/2001 | EP1154786A2 Methods and compositions for altering mucus secretion |
| 11/21/2001 | EP1154785A2 Inhibitors for use in hemostasis and immune function |
| 11/21/2001 | EP1154784A1 Therapeutically active mixture of substances containing s-acetylglutathione and aciclovir |
| 11/21/2001 | EP1154783A1 Medicaments comprising relaxin and their use |
| 11/21/2001 | EP1154769A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen |
| 11/21/2001 | EP1154764A1 Epoxide hydrolase complexes and methods therewith |
| 11/21/2001 | EP1154759A1 Dispersible concentrate for the delivery of cyclosporin |
| 11/21/2001 | EP1154701A1 Milk protein hydrolysate for addressing a bone or dental disorder |
| 11/21/2001 | EP1154691A1 Targeted transscleral controlled release drug delivery to the retina and choroid |
| 11/21/2001 | EP1007085B1 Use of growth hormone in compositions for treating insulin resistance in the heart |
| 11/21/2001 | EP0895473B1 Polysaccharide microspheres for the pulmonary delivery of drugs |
| 11/21/2001 | EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 11/21/2001 | EP0852492B1 Transdermal matrix system |
| 11/21/2001 | EP0852469B1 Use of threonine for the treatment of phenylketonuria |
| 11/21/2001 | EP0842191B1 Cyclosporin derivatives with anti-hiv activity |
| 11/21/2001 | EP0773962B1 Antibodies which activate an erythropoietin receptor |
| 11/21/2001 | EP0767676B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 11/21/2001 | EP0765168B1 Combination of a procoagulant and a cytokine or an inducer of cytokine production for the treatment of tumors |
| 11/21/2001 | EP0711305B1 Protegrins |
| 11/21/2001 | EP0703788B1 A stabilised phenylalanine ammonia lyase |
| 11/21/2001 | EP0659179B1 Benzo-fused lactams promote release of growth hormone |
| 11/21/2001 | EP0644944B1 Adeno-associated virus with inverted terminal repeat sequences as promoter for the in vivo transfer of a functional cftr gene |
| 11/21/2001 | EP0644768B1 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation |
| 11/21/2001 | EP0536186B1 Bone and cartilage inductive proteins |
| 11/21/2001 | CN1323348A Delivery system for porcine somatotropin |
| 11/21/2001 | CN1323346A TPL-2/COT kinase and methods of use |
| 11/21/2001 | CN1323345A A modified polypeptide with reduced immune response |
| 11/21/2001 | CN1323316A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
| 11/21/2001 | CN1323315A 5-membered ring compounds |
| 11/21/2001 | CN1323314A Inhibitors of caspases |
| 11/21/2001 | CN1323225A Polymer conjugates of interferon beta-1a and their uses |
| 11/21/2001 | CN1323223A Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 11/21/2001 | CN1323221A Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide |
| 11/21/2001 | CN1323220A Insulin preparations for pulmonary delivery containing menthol |
| 11/21/2001 | CN1323219A Stable concentrated insulin preparations for pulmonary delivery |
| 11/21/2001 | CN1323218A The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives |
| 11/21/2001 | CN1323216A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 11/21/2001 | CN1323213A Blood-brain barrier therapeutics |
| 11/21/2001 | CN1323203A FC receptor modulators and uses thereof |
| 11/21/2001 | CN1323165A Protein material for slow digestion and its use |
| 11/21/2001 | CN1323159A Method for preserving a hemoglobin blood substitute |
| 11/21/2001 | CN1322839A New polypeptide human triose-phosphate isomerase 10 and its encoding polynucleotides |
| 11/21/2001 | CN1322838A New polypeptide human ATP dependent serine proteinase 10 and its encoding polynucleotides |
| 11/21/2001 | CN1322837A New polypeptide human ATP dependent serine proteinase 11 and its encoding polynucleotides |
| 11/21/2001 | CN1322836A New polypeptide human ATP dependent serine proteinase 11 and its encoding polynucleotides |
| 11/21/2001 | CN1322835A New polypeptide human ATP dependent serine proteinase 12 and its encoding polynucleotides |
| 11/21/2001 | CN1322834A New polypeptide human ATP dependent serine proteinase 9.2 and its encoding polynucleotides |
| 11/21/2001 | CN1322831A New polypeptide human uncoiling enzyme 11 and its encoding polynucleotides |
| 11/21/2001 | CN1322830A New polypeptide human focal adhesion kinase (FAK) 13 and its encoding polynucleotides |
| 11/21/2001 | CN1322824A New polypeptide human aldehyde/ketone reductase 12 and its encoding polynucleotides |
| 11/21/2001 | CN1322823A New polypeptide human aldehyde/ketone reductase 10 and its encoding polynucleotides |
| 11/21/2001 | CN1322818A New polypeptide human class-II aminoacyl-tRNA synthetase 10 and encoding polynucleotide of the same polypeptide |
| 11/21/2001 | CN1322817A New polypeptide human ubiquitin conjugated enzyme 10.2 and its encoding polynucleotides |
| 11/21/2001 | CN1322761A Animal hematoglobin and its extraction process and use |
| 11/21/2001 | CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof |
| 11/21/2001 | CN1322752A New polypeptide human Pax protein 22 and its encoding polynucleotides |
| 11/21/2001 | CN1322750A New polypeptide human ribosomal protein S18-14 and its encoding polynucleotides |
| 11/21/2001 | CN1322749A New polypeptide human ribosomal protein S18-12 and its encoding polynucleotide |
| 11/21/2001 | CN1322744A New polypeptide human CCR4 related protein 10 and its encoding polynucleotides |
| 11/21/2001 | CN1322740A New polypeptide human SOX9 protein 13 and its encoding polynucleotides |
| 11/21/2001 | CN1322738A New polypeptide human cannabol receptor 11 and its encoding polynucleotides |